Mot-2 protein is shown to interact with p53 and inhibit its transcriptional activation function. Mot-2 overexpressing stable clones of NIH 3T3 cells were malignantly transformed, however, they had a high level of expression of a p53 downstream gene, p21
INTRODUCTION
Multiple cellular functions of p53, a most frequently mutated tumor suppressor in human cancers, are involved in its ability to induce and regulate cell cycle arrest and apoptosis [1, 2] . Among these are its ability to bind to specific DNA sequences and activate transcription of genes such as, mdm-2, p21 WAF1 , gadd45, bax and IGFBP-3 [3] [4] [5] [6] . p21 WAF1 , the pioneer member of p21 family of cyclin-cdk inhibitor class of proteins (p21
WAF1
, p27 Kip1 
and p57
Kip2 ), that bind to cyclin D1 [7, 8] has been implicated as a growth arrest mediator in p53-tumour suppression, cellular senescence and terminal differentiation. Similarly, another class of cyclincdk inhibitors, INK4 family members (p16 INK4a , p15
INK4b , p18
INK4c and p19 INK4d ) that bind to cdk-4 and cdk-6 [9] [10] [11] regulate cell cycle progression. By inactivating the cyclin-cdk complexes, these inhibitors block phosphorylation of RB family of proteins (RB) and abrogate release of E2F (required for cell cycle progression) from RB-E2F complexes [12] . Number of studies have supported that p21 WAF1 functions during normal and induced cellular senescence [13] [14] [15] [16] [17] . However, mice lacking p21 WAF1 have normal phenotype [18] , [19] and its upregulation has been detected by mitogenic and growth stimulatory signals [20] , [21] . These data suggested that physiological function of p21 WAF1 may not be limited to execution of cell cycle arrest program.
Mot-2, a member of hsp70 family protein, was seen to interact with p53 and inactivate its transactivation function by abrogating its nuclear translocation [22] . While characterizing mouse fibroblasts stably transfected with mot-2, we found that in spite of inactivation of the p53 function by mot-2, these cells have high level of p21
WAF1
. Studies were therefore undertaken to elucidate the , cyclin D1 and cdk-2 in stablyand transiently-transfected cells suggested that the upregulation of p21WAF1 in stable NIH 3T3/mot-2 cells may occur possibly by post-transcriptional and p53-independent mechanism(s) such as those mediated by cyclin D1, cdk-2 and E2F.
MATERIAL AND METHODS

Cell culture
NIH 3T3 cells were transfected (LipofectAMINE TM , Life Technologies, Inc) with expression plasmid encoding mouse mot-2 protein and the stable clones were isolated and maintained in 50 g/ml G418-supplemented growth medium (Dulbecco's modified Eagle s minimal essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS) as described [23] . Normal mouse embryonic fibroblasts (CMEF) from CD1-ICR mouse and their spontaneously immortalized clone, RS-4, were serially passaged similarly by 1:8 subculturing in DMEM.
Northern blot analysis
RNA from NIH 3T3 and its mot-2 derivatives were extracted by using Isogen (GibcoBRL). Northern analysis for p21 WAF1 was performed by using 10 mg of total RNA, separated on 1.5% denaturing agarose gel, transferred to Hybond N (Amersham) membrane by capillary transfer, and probed with the 32P-radiolabeled mouse p21
WAF1 cDNA (kindly provided by Dr. Olivia M. Pereira-Smith).
Western blot analysis
The protein sample (10-20 mg) separated on an SDS-polyacrylamide gel was electroblotted onto a nitrocellulose membrane (BA85, Schleicher and Schuell) using a semidry transfer blotter (Biometra, Tokyo). Immunoassays were performed with anti-mortalin [24] , -p21 (M-19, Santa Cruz), -p16
INK4a (M156, Santa Cruz), -cdk-2 (M2, Santa Cruz), -cdk-4 (C-22, Santa Cruz), -cdk-6 (c-21, Santa Cruz), -cyclin D1 (72-13G, Santa Cruz) or anti-actin (Boehringer Mannheim) antibodies. The immunocomplexes formed were visualized either with horseradish peroxidase (HRP) or alkaline phosphate-conjugated antimouse/rabbit immunoglobulin G (IgG) (ECL kit, Amersham Pharmacia Biotech).
RESULTS AND DISCUSSION
NIH 3T3/mot-2 cells show an upregulation of p21WAF1 expression
Western analysis with anti-p21 antibody revealed a high expression level of p21 WAF1 in NIH 3T3/mot-2 cells as compared to untransfected and vector-transfected cells. This was contrary to the inactivation of p53 function by mot-2 [22] , [25] . We first ascertained that the band detected on Western blot was indeed p21
WAF1 by using serially passaged normal mouse embryonic fibroblasts (CMEF) and NIH 3T3 cells cultured at different density ( Fig 1A) . In agreement to known pattern of p21WAF1 expression in senescence human cells [13] , [26] , it was seen to undergo upregulation with in vitro aging of mouse cells. CMEF cells at passage 6-8 showed senescent morphology following which spontaneously immortalized clones emerged. One of such clones, RS-4 that showed mutant p53 [27] was also assayed for p21 expression level ( Fig  1A) . In spite of the presence of mutant p53, RS-4 cells showed the p21 WAF1 expression, albiet at level less than the one detected in cells at senescent phase (passage 8), suggesting p53-independent expression of p21WAF1. However, p21
WAF1 expression in RS-4 cells was not induced by high-density culture in contrast to NIH 3T3 cells that have wild type p53 protein (Fig 1A) . These data established that the band detected on our Westerns represented p21 WAF1 . NIH 3T3/mot-2 cells (two independent clones) showed a high level of expression of p21 WAF1 even at low-density culture and did not support inactivation of p53 function by mot-2 in these cells (Fig 1A) . A p53-independent increase in the level of p21
WAF1 expression of by post-transcriptional [28] and post-translational [29] mechanism has been reported. Therefore, to detect the level at which p21 WAF1 had undergone upregulation in NIH 3T3/ mot-2 cells, we next performed Northern analysis. Consistent with Western blot analysis, a high level of transcript was apparent in NIH 3T3/mot-2 cells (Fig 1B) implementing that in these cells upregulation of p21 WAF1 occurred at transcriptional level. Since these cells show inactivation of p53 function [22] , [25] , it is likely that upregulation of p21 WAF1 occurred either by p53-independent pathway or involves post-transcriptional mechanisms. We also performed p53 dependent reporter assays in NIH 3T3 and NIH 3T3/mot-2 cells. The activity of the full length p21 WAF1 promoter reporter plasmid was three-five fold high in NIH 3T3 cells in different experiments [22] , [25] and data not shown]. This suggested that the high level of p21 WAF1 transcript in NIH 3T3/mot-2 cells is either regulated by elements located further upstream to the 2501 bp in the promoter used in the reporter plasmid or by post-transcriptional mechanism(s).
p53-independent upregulation of p21
Identity of the parent NIH 3T3 and its mot-2 derivative was affirmed by Western blot analysis with anti-p16
INK4a antibody (Fig 1C) . Consistent with the upregulation of p16
INK4A during senescence of mouse and human cells [9] , [30] [31] [32] [33] INK4a was detected in CMEF during serial passaging. Similar to NIH 3T3, NIH 3T3/mot-2 cells lack the expression of p16
INK4a and served as a fingerprint for these cells.
expression and were nonmalignant in their growth properties. It has been shown that mice that carry targeted deletions of p16 INK4a locus developed spontaneous tumors at an early age and are highly sensitive to carcinogenic treatment [35] . p16-/-mouse embryonic fibroblasts proliferate rapidly in culture, grow at high densities and show a high colony forming efficiency. An introduction of p16
INK4a to human gliomas that undergo frequent loss of p16
INK4a induces cellular senescence [32] . Such functions of p16
INK4a and its presence in RS-4 cells may be related to their nonmalignant phenotype in spite of the presence of mutant p53 and other transformation favoring characteristics [27] , [36] .
Taken together, these data presented evidence for post-transcriptional and p53-independent upregulation of p21 WAF1 expression. Other examples of p53-independent increase in p21
WAF1 expression include hepatocytes following carbon tetrachloride intoxication [37] , hematopoietic and hepatoma cells during differentiation [38] , human melanoma cells during IFN-b and MEZ induced growth arrest and terminal differentiation [39] , myeloid leukemic cells during terminal differentiation by a hormonal form of vitamin D [40] .
An amplification of p21WAF1 from NIH 3T3 and NIH 3T3/mot-2 cells by RT-PCR and sequence analysis (data not shown) of the amplified DNA product confirmed the wild type nature of p21 WAF1 in malignantly transformed NIH 3T3/mot-2 cells. This indicated that an increased level of expression of p21 WAF1 does not correlate with its cell cycle arrest function and may have some other function (s). In this context, elevated levels of p21 WAF1 expression have been detected in gliomas [41] , non small cell lung carcinomas [21] , [42] , invasive cervical cancer [43] and bladder carcinomas [44] . A 50-100 fold increase in p21 WAF1 expression has been detected in NIH 3T3 cells transformed with activated Ras oncogene [20] .
Cyclin D1 and cdk-2 are upregulated in stable NIH 3T3/mot-2 cells An ectopic expression of cyclin D1 has been found to result in increased expression of p21 WAF1 in human glioma and rodent fibroblasts that were morphologically transformed [45] . Such induction of p21
WAF1 has been suggested to be mediated by E2F; an E2F binding site is found in p21Waf1 promoter [46] . A positive feed back regulation between cyclin D1 and p21 WAF1 has been proposed. Cyclin D1/cdk-4 phosphorylate pRb and generate free E2F that can initiate p21 WAF1 transcription. Under the conditions when cyclin D1 levels are higher than p21 WAF1 , cells continue to divide and are unlikely to respond to p21-mediated growth inhibitory signals resulting into cellular transformation. Conversely, when p21
WAF1 levels are greater than cyclin D1, cell cycle machinery is suppressed and/ or shifted towards the direction of differentiation. Since NIH 3T3/mot-2 cells were seen to have a higher level of expression of p21
WAF1 as compared to NIH 3T3 and CMEF cells, we next analyzed the expression of cyclin D1 in these cells (Fig 2A) . A higher level of cyclin D1 was detected in NIH 3T3/ mot-2 cells elucidating a factor that may positively affect p21
WAF1 expression by abrogation of RB function through phosphorylation. Since active complexes of cyclin-cdks are essential for phosphorylation/ablation of tumor suppressor function of pRb for the release free E2F, we next analyzed expression profiles for cdk-2, cdk-4 and cdk-6 in NIH 3T3/mot-2 cells (Fig 2B) . A low molecular mass band (the active form) of cdk-2 was detected at higher level in NIH 3T3/mot-2 as compared to NIH 3T3 cells. These data submit that such upregulated cdk-2 expression is likely to cooperate with cyclin D1 to phosphorylate RB and subsequent E2F-mediated increase in p21
WAF1 expression in NIH 3T3/mot-2 cells as suggested above.
In contrast to the stable clones, transiently transfected cells showed decreased expression of p21 WAF1 [22] . If the above described changes in cyclin D1 and cdk-2 are the antecedent for upregulated p21
WAF1 expression, we reasoned that these changes should not be detected in transient transfectants. Indeed, in contrast to the stable clones, no change in the level of expression of cyclin D1 and cdk-2 was detected (Fig 2C) suggesting that upregulation of p21 WAF1 in stable NIH 3T3/mot-2 cells may be mediated, at least in part, by upregulated cyclin D1 and cdk-2. The most likely mechanism of upregulated p21
WAF1 expression appears to be arbitrated by active E2F, engendered by phosphorylation of RB that is caused by upregulated cyclin D1 and cdk-2. Mechanism of mot-2 interposed active cyclin D1 and cdk-2 levels in stable NIH 3T3/mot-2 cells and its absence in cells transiently transfected with plasmids encoding GFP-tagged mot-2 protein warrant further investigations.
In summary we have shown p53-independent upregulation of p21 WAF1 in NIH 3T3 cells that are malignantly transformed by mot-2.
